(4,4-dimethyl-pent-2-ynyl)-dimethyl-amine | 52324-00-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (4,4-dimethyl-pent-2-ynyl)-dimethyl-amine
• 英文别名: 1-Dimethylamino-4,4-dimethyl-pent-2-in；(4,4-Dimethyl-pent-2-inyl)-dimethyl-amin；N,N,4,4-tetramethylpent-2-yn-1-amine
• CAS: 52324-00-2
• 化学式: C₉H₁₇N
• 分子量: 139.241
• InChiKey: AUWQKAPYXGLUFC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  聚合甲醛 、 3,3-二甲基-1-丁炔 、 二甲胺 在 1,4-二氧六环 、 copper (I) acetate 作用下， 生成 (4,4-dimethyl-pent-2-ynyl)-dimethyl-amine
  参考文献：
  名称：

  Marszak et al., Memorial des services chimiques de l'Etat, 1951, vol. 36, p. 301,307

  摘要：

  DOI：

文献信息

• Mechanistic Insights into the One-Pot Synthesis of Propargylamines from Terminal Alkynes and Amines in Chlorinated Solvents Catalyzed by Gold Compounds and Nanoparticles
  作者：David Aguilar、Maria Contel、Esteban P. Urriolabeitia

  DOI：10.1002/chem.201000587

  日期：——

  Propargylamines can be obtained from secondary amines and terminal alkynes in chlorinated solvents by a three‐ and two‐component synthesis catalyzed by gold compounds and nanoparticles (Au‐NP) under mild conditions. The use of dichloromethane allows for the activation of two CCl bonds and a clean transfer of the methylene fragment to the final product. The scope of the reaction as well as the influence

  炔丙基胺可以在温和的条件下，由金化合物和纳米颗粒（Au-NP）催化的三组分和二组分合成，从氯化胺中的仲胺和末端炔烃获得。使用二氯甲烷可激活两个CCl键，并将亚甲基片段完全转移至最终产物。已经研究了反应的范围以及不同的金（III）环金络合物和盐的影响。讨论了原位生成的金纳米粒子的参与过程，并根据获得的数据提出了合理的反应机理。
• Novel high affinity quinoline-based kinase ligands
  申请人：Deng Yongqi

  公开号：US20080045568A1

  公开（公告）日：2008-02-21

  Quinoline-based inhibitors of cyclin dependent kinase 2, compositions including the inhibitors, and methods of using the inhibitors and inhibitor compositions are described. The inhibitors and compositions including them are useful for treating disease or disease symptoms. The invention also provides for methods of making CDK-2 inhibitor compounds, methods of inhibiting CDK-2, and methods for treating disease or disease symptoms.

  基于喹啉的细胞周期蛋白依赖激酶2抑制剂，包括这些抑制剂的组合物，以及使用这些抑制剂和抑制剂组合物的方法。这些抑制剂和包括它们的组合物对治疗疾病或疾病症状有用。该发明还提供了制备CDK-2抑制剂化合物的方法，抑制CDK-2的方法，以及治疗疾病或疾病症状的方法。
• 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
  申请人：Genentech, Inc.

  公开号：US20150336962A1

  公开（公告）日：2015-11-26

  Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

  这里描述了化合物的公式（00A）及其作为Janus激酶抑制剂的使用方法。
• Inhibitors of VEGF receptor and HGF receptor signaling
  申请人：Saavedra Mario Oscar

  公开号：US20070004675A1

  公开（公告）日：2007-01-04

  The invention relates to the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention provides compounds and methods for inhibiting VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions

  该发明涉及抑制VEGF受体信号和HGF受体信号。该发明提供了抑制VEGF受体信号和HGF受体信号的化合物和方法。该发明还提供了治疗细胞增殖性疾病和病况的组合物和方法。
• Inhibitors of protein tyrosine kinase activity
  申请人：Raeppel Stephane

  公开号：US20080004273A1

  公开（公告）日：2008-01-03

  This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

  这项发明涉及抑制蛋白酪氨酸激酶活性的化合物。具体而言，该发明涉及抑制生长因子受体蛋白酪氨酸激酶活性的化合物，导致受体信号传导的抑制，例如抑制VEGF受体信号传导和HGF受体信号传导。更具体地，该发明涉及用于抑制VEGF受体信号传导和HGF受体信号传导的化合物、组合物和方法。该发明还提供了用于治疗细胞增殖性疾病和病况的组合物和方法。